Literature DB >> 26043345

Need for a realistic appraisal of benzodiazepines.

Richard Balon1, Giovanni A Fava2,3, Karl Rickels4.   

Abstract

Entities:  

Year:  2015        PMID： 26043345      PMCID： PMC4471984          DOI： 10.1002/wps.20219

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  15 in total

Review 1.  Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations.

Authors:  Anja Cerovecki; Richard Musil; Ansgar Klimke; Florian Seemüller; Ekkehard Haen; Rebecca Schennach; Kai-Uwe Kühn; Hans-Peter Volz; Michael Riedel
Journal:  CNS Drugs       Date:  2013-07       Impact factor: 5.749

2.  Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.

Authors:  A E Nardi; A M Valença; R C Freire; M D Mochcovitch; R Amrein; A Sardinha; M N Levitan; I Nascimento; V L de-Melo-Neto; A L King; A C de O E Silva; A B Veras; G P Dias; G L Soares-Filho; R T da Costa; M A Mezzasalma; M R de Carvalho; A C de Cerqueira; J E Hallak; J A Crippa; M Versiani
Journal:  Braz J Med Biol Res       Date:  2011-02-18       Impact factor: 2.590

Review 3.  Drug therapy. Current status of benzodiazepines.

Authors:  D J Greenblatt; R I Shader; D R Abernethy
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

4.  A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.

Authors:  Antonio E Nardi; Rafael C Freire; Marina D Mochcovitch; Roman Amrein; Michelle N Levitan; Anna L King; Alexandre M Valença; André B Veras; Flávia Paes; Aline Sardinha; Isabella Nascimento; Valfrido L de-Melo-Neto; Gisele P Dias; Adriana Cardoso de O E Silva; Gastão L Soares-Filho; Rafael T da Costa; Marco A Mezzasalma; Marcele R de Carvalho; Ana C de Cerqueira; Jaime E Hallak; José A Crippa; Marcio Versiani
Journal:  J Clin Psychopharmacol       Date:  2012-02       Impact factor: 3.153

Review 5.  What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors.

Authors:  Margrethe Nielsen; Ebba Holme Hansen; Peter C Gøtzsche
Journal:  Addiction       Date:  2012-01-23       Impact factor: 6.526

6.  Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.

Authors:  James K Walsh; Andrew D Krystal; David A Amato; Robert Rubens; Judy Caron; Thomas C Wessel; Kendyl Schaefer; James Roach; Gene Wallenstein; Thomas Roth
Journal:  Sleep       Date:  2007-08       Impact factor: 5.849

Review 7.  Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.

Authors:  Emanuela Offidani; Jenny Guidi; Elena Tomba; Giovanni Andrea Fava
Journal:  Psychother Psychosom       Date:  2013-09-20       Impact factor: 17.659

8.  Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.

Authors:  Andrew D Krystal; Milton Erman; Gary K Zammit; C Soubrane; Thomas Roth
Journal:  Sleep       Date:  2008-01       Impact factor: 5.849

Review 9.  The reappraisal of benzodiazepines in the treatment of anxiety and related disorders.

Authors:  Vladan Starcevic
Journal:  Expert Rev Neurother       Date:  2014-09-22       Impact factor: 4.618

10.  Benzodiazepine use and risk of Alzheimer's disease: case-control study.

Authors:  Sophie Billioti de Gage; Yola Moride; Thierry Ducruet; Tobias Kurth; Hélène Verdoux; Marie Tournier; Antoine Pariente; Bernard Bégaud
Journal:  BMJ       Date:  2014-09-09
View more
  2 in total

1.  The prevalence of benzodiazepines utilization and its association with falls among Saudi older adults; results from the Saudi national survey for elderly Health (SNSEH).

Authors:  Mohammad H Aljawadi; Abdullah T Khoja; Abdullah M Alhammad; Azzam D AlOtaibi; Sulaiman A Al-Shammari; Tawfik A Khoja
Journal:  Saudi Pharm J       Date:  2018-05-31       Impact factor: 4.330

2.  Attitudes towards a maintenance (-agonist) treatment approach in high-dose benzodiazepine-dependent patients: a qualitative study.

Authors:  Michael Liebrenz; Marcel Schneider; Anna Buadze; Marie-Therese Gehring; Anish Dube; Carlo Caflisch
Journal:  Harm Reduct J       Date:  2016-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.